Protein Science, Vol 7, Issue 4 886-896, Copyright © 1998 by Cold Spring Harbor Laboratory Press

ARTICLE

LIF receptor-gp130 interaction investigated by homology modeling: Implications for LIF binding

D. K. SMITH and H. R. TREUTLEIN
Molecular Modelling Group, Ludwig Institute for Cancer Research, and Cooperative Research Centre for Cellular Growth Factors, Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia Biochemistry Department, University of Melbourne, Parkville, Victoria, 3052, Australia Present address: Biochemistry Department, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong.

Leukemia inhibitory factor (LIF), a member of the gp130 family of helical cytokines, is involved in the hemopoietic and neural systems. The LIF signal transducing complex contains two receptor molecules, the LIF receptor (LIFR) and gp130. The extracellular region of the LIFR is unique in that it includes three membrane-proximal fibronectin type III domains and two cytokine binding domains (CBDs) separated by an immunoglobulin-like domain. Although some mutagenesis data on LIF are available, it is not yet known which regions of LIFR or gp130 bind LIF. Nor is it known whether LIFR contacts gp130 in a manner similar to the growth hormone receptor dimer and, if so, through which of its CBDs. To attempt to elucidate these matters and to investigate the receptor complex, models of the CBDs of LIFR and the CBD of gp130 were constructed. Analyses of the electrostatic isopotential surfaces of the CBD models suggest that gp130 and the membrane-proximal CBD of LIFR hetero-dimerize and bind LIF through contacts similar to those seen in the growth hormone receptor dimer. This work further demonstrates the utility of electrostatic analyses of homology models and suggests a strategy for biochemical investigations of the LIF-receptor complex.
CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Magni, E. Dozio, M. Ruscica, H. Watanobe, A. Cariboni, R. Zaninetti, M. Motta, and R. Maggi Leukemia Inhibitory Factor Induces the Chemomigration of Immortalized Gonadotropin-Releasing Hormone Neurons through the Independent Activation of the Janus Kinase/Signal Transducer and Activator of Transcription 3, Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase 1/2, and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways Mol. Endocrinol., May 1, 2007; 21(5): 1163 - 1174. [Abstract] [Full Text] [PDF]

				F. M. Smith, C. Vearing, M. Lackmann, H. Treutlein, J. Himanen, K. Chen, A. Saul, D. Nikolov, and A. W. Boyd Dissecting the EphA3/Ephrin-A5 Interactions Using a Novel Functional Mutagenesis Screen J. Biol. Chem., March 5, 2004; 279(10): 9522 - 9531. [Abstract] [Full Text] [PDF]

				D. Man, W. He, K. H. Sze, K. Gong, D. K. Smith, G. Zhu, and N. Y. Ip Solution Structure of the C-terminal Domain of the Ciliary Neurotrophic Factor (CNTF) Receptor and Ligand Free Associations among Components of the CNTF Receptor Complex J. Biol. Chem., June 20, 2003; 278(26): 23285 - 23294. [Abstract] [Full Text] [PDF]

				M.-B. Voisin, J. Bitard, S. Daburon, J.-F. Moreau, and J.-L. Taupin Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation J. Biol. Chem., April 12, 2002; 277(16): 13682 - 13692. [Abstract] [Full Text] [PDF]

				J.-L. Taupin, P. Legembre, J. Bitard, S. Daburon, V. Pitard, F. Blanchard, L. Duplomb, A. Godard, Y. Jacques, and J.-F. Moreau Identification of Agonistic and Antagonistic Antibodies against gp190, the Leukemia Inhibitory Factor Receptor, Reveals Distinct Roles for Its Two Cytokine-binding Domains J. Biol. Chem., December 14, 2001; 276(51): 47975 - 47981. [Abstract] [Full Text] [PDF]

				C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text]

				A. R. Cole, N. E. Hall, H. R. Treutlein, J. S. Eddes, G. E. Reid, R. L. Moritz, and R. J. Simpson Disulfide Bond Structure and N-Glycosylation Sites of the Extracellular Domain of the Human Interleukin-6 Receptor J. Biol. Chem., March 12, 1999; 274(11): 7207 - 7215. [Abstract] [Full Text] [PDF]

				R. L. Moritz, N. E. Hall, L. M. Connolly, and R. J. Simpson Determination of the Disulfide Structure and N-Glycosylation Sites of the Extracellular Domain of the Human Signal Transducer gp130 J. Biol. Chem., March 9, 2001; 276(11): 8244 - 8253. [Abstract] [Full Text] [PDF]